Preparation in high-shear mixer of sustained-release pellets by melt pelletisation

International Journal of Pharmaceutics

Volumn 203, Issue 1-2, 2000, Pages 235-244

  Voinovich, D ^a   Moneghini, M ^a   Perissutti, B ^a   Filipovic Grcic, J ^b   Grabnar, I ^c  

^a UNIVERSITY OF TRIESTE   (Italy)

^b UNIVERSITY OF ZAGREB   (Croatia)

^c UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

Doehlert design; High shear mixer; Melt pelletisation; Sustained release

Indexed keywords

THEOPHYLLINE;

ARTICLE; CONTROLLED STUDY; DRUG DESIGN; DRUG SYNTHESIS; MELTING POINT; METHODOLOGY; NONHUMAN; PARTICLE SIZE; POROSITY; PRIORITY JOURNAL; ROENTGEN SPECTROSCOPY; SCANNING ELECTRON MICROSCOPY; SUSTAINED RELEASE PREPARATION;

ADULT; BIOLOGICAL AVAILABILITY; DELAYED-ACTION PREPARATIONS; FEMALE; HUMANS; MALE; SOLUBILITY; THEOPHYLLINE;

EID: 0034255003     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(00)00455-5     Document Type: Article

References (16)

1. Adeyeye C.M., Price J.C. Development and evaluation of sustained release ibuprofen-wax microspheres. II. In vitro dissolution studies. Pharm. Res. 11:1994;575-579.
2. Campisi B., Vojnovic D., Chicco D., Phan-Tan-Luu Melt granulation in a high shear mixer: optimization of mixture and process variables using a compined experimental design. Chem. Int. Lab. Syst. 48:1999;59-70.
3. Carli F., Garbassi F. Characterisation of drug loading in crospovidone by X-ray photoelectron spectroscopy. J. Pharm. Sci. 74:1985;963-967.
4. Doehlert D.H. Uniform shell design. Appl. Stat. 19:1970;231-239.
5. Henrist D., Lefebvre R.A., Remon J.P. Bioavailability of starch based hot stage extrusion formulations. Int. J. Pharm. 187:1999;185-191.
6. Jonkman J.H.G., Steinijans V.W., Beier W., van der Boon W.J.V., Crasmeijer G. Sustained release properties of the once daily theophylline capsule BY912 as compared with Theo-24® capsules. Biopharm. Drug Dispos. 10:1989;213-224.
7. Mathieu D., Nony J., Phan-Tan-Luu R. NEMRODW (New Efficient Tecnhnology for research using Optimal Design). 1999;L.P.R.A.I. Marseille. software.
8. McTaggart C.M., Ganley J.A., Sickmneller A., Walker S.E. The evaluation of formulation and processing conditions of a melt granulation process. Int. J. Pharm. 19:1984;139-148.
9. Peppas N.A. Analysis of Fickian and non-Fickian drug release from polymers. Pharm. Acta. Helv. 60:1985;110-121.
10. Schaefer T. Melt agglomeration with polyethylene glycols in high shear mixer. 1997;The Royal Danish School of Pharmacy, Denmark. Ph.D. Thesis.
11. Thies R., Kleinebudde P. Melt pellettisation of a hygroscopic drug in a high shear mixer. Part 1. Influence of process variables. Int. J. Pharm. 188:1999;131-143.
12. Voinovich D., Campisi B., Moneghini M., Vincenzi C., Phan-Tan-Luu R. Screening of high shear mixer melt granulation process variables using an asymmetrical factorial design. Int. J. Pharm. 190:1999;73-81.
13. Vojnovic D., Rupena P., Moneghini M., Rubessa F., Coslovich S., Phan-Tan-Luu R., Sergent M. Experimental research methodology applied to wet pelletization in a high shear mixer. Part I. S.T.P. Pharma Sci. 3:1993;130-135.
14. Vojnovic D., Moneghini M., Rubessa F. Experimental design for a granulation process with a priori criterias. Drug Dev. Ind. Pharm. 21:1995;823-831.
15. Yuen K.H., Deshmukh, Newton J.M., Short M., Melchor R. Gastrointestinal transit and absorption of theophylline from a multiparticulate controlled release formulation. Int. J. Pharm. 97:1993;61-77.
16. Zhou F., Vervaet C., Remon J.P. Matrix pellets on the combination of waxes, starches and maltodextrins. Int. J. Pharm. 133:1996;155-160.